Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
fMRI to Predict Stimulant Response in Adult ADHD
NCT01858064Phase 4Withdrawn
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2015
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Massachusetts General Hospital. Planned start Apr 2015; status: withdrawn.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01858064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01858064.